Does biotechnological innovation require organizational innovation?
Résumé
Genomic innovation can give rise to many uncertainties.New uncertainties induced by genomic innovation change the room to maneuver and upset actor’s behaviors, disrupting individual and collective strategies. A French case study shows that the new operational and organizational strategies have to upscale and pool some resources, and at the same time, enable competition and entrepreneurial freedom. Genomic innovation gives rise to new strategies and to organizational innovations, pointing to the need for regulatory innovation.